NOV 21, 2019 9:00 AM PST

The role of immune cells and immune checkpoints in multiple myeloma

Speaker
  • PhD candidate, University Hospital Bonn, Germany
    Biography
      Nathalie is currently a PhD student at the Department for Oncology, Immunology and Hematology at the University Hospital Bonn in Germany.
      She is working in the biomedical research laboratory under the direction of Prof. Dr. Peter Brossart. Her thesis focuses on immunotherapy in multiple myeloma.
      Currently she investigates the regulation of immune cells and the expression of immune checkpoints e.g. by using CRISPR/Cas9 technology and flow cytometry.

      Nathalie accomplished her studies in biochemistry at the Heinrich-Heine University of Düsseldorf, Germany, in 2014. For her master thesis she went to the laboratory of Prof. Ruth J. Muschel at the University of Oxford, UK. There she studied the role of myeloid cells in liver metastasis e.g. by using immunohistochemistry and lentiviral transfections.

      While she is very passionate about basic cancer research, equally important to her is science communication and health education.

    Abstract
    DATE:  November 21, 2019
    TIME:   9:00am PST, 12:00pm EST
     
    Multiple Myeloma is a disease of terminally differentiated plasma cells with the massive production of monoclonal immunoglobulins in the bone marrow.

    Today there are many treatment modalities ongoing targeting the myeloma microenvironment, but especially immunotherapy seems to be a promising approach.

    Immune checkpoints are critical components in the regulation of immune cell responses. If immune cells are activated due to the contact to an antigen, they also need to be controlled to prevent an overactive immune response. These control checkpoints are often over-expressed in cancer cells and therefore protect them from the tumour-specific immune response enabling tumour immune escape.
    We investigate the role of the PD-1/PD-L1 immune checkpoint during myeloma disease progression and determine combinatorial approaches of immunotherapeutic drugs to increase myeloma cell killing efficiency.
     
    Learning Objectives:
    • Identify tumour immune microenvironment
    • Examine immunotherapeutic strategies for hematologic malignancies
    • Discuss flow cytometry to investigate immune cell regulation in multiple myeloma
     
    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    MAR 16, 2021 10:00 AM PDT
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    NOV 21, 2019 9:00 AM PST

    The role of immune cells and immune checkpoints in multiple myeloma


    Specialty

    Immunology

    Cancer Research

    Molecular Biology

    Cell Biology

    Laboratory Testing

    Molecular Diagnostics

    Clinical Diagnostics

    Cancer Therapeutics

    Cancer Diagnostics

    Biotechnology

    Biomarkers

    Microbiology

    Genetics

    Clinical Research

    Infectious Disease

    Geography

    North America66%

    Europe16%

    Asia11%

    Africa3%

    South America2%

    Oceania1%

    Registration Source

    Email Promotions45%

    Website Visitors42%

    WAVE Newsletter Promotion4%

    Trending Newsletter Promotion2%

    Other6%

    Job Title

    Medical Laboratory Technician18%

    Scientist11%

    Research Scientist10%

    Executive9%

    Clinical Laboratory Scientist9%

    Student9%

    Educator/Faculty8%

    Facility/Department Manager8%

    Lab Management6%

    Medical Doctor/Specialist5%

    Post Doc3%

    Genetic Counselor1%

    Chemist1%

    Other1%

    Organization

    Academic Institution20%

    Hospital18%

    Clinical Laboratory13%

    Biotech Company9%

    Pharmaceutical Company7%

    Research Institute4%

    Medical Center4%

    Government3%

    Medical School3%

    Contract Research Organization (Cro)2%

    Non-Profit Organization2%

    Life Science Company1%

    Diagnostic Company1%

    Independent Laboratories1%

    Other3%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more